2702, Rush University CRS — Chicago, Illinois

2702, Rush University CRS is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

2702, Rush University CRS has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acute HIV Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 2702, Rush University CRS?

2702, Rush University CRS has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 2702, Rush University CRS conducted?

2702, Rush University CRS has 1 clinical trials on record, with 1 currently active. Their work covers Acute HIV Infection.

Is 2702, Rush University CRS accredited by Crixeo Health?

2702, Rush University CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 2702, Rush University CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.